Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
- Details
- Category: Abbott
![Abbott (NYSE: ABT) Abbott (NYSE: ABT)](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
Eli Lilly and Company Announces New Drug Discovery Initiative
- Details
- Category: Eli Lilly and Company
![Lilly Lilly](http://www.worldpharmanews.com/images/stories/logo/lilly.gif)
Alzheimer's disease. Cancer. Diabetes. Osteoporosis.
These are the diseases for which Eli Lilly and Company will be engaging researchers from around the world in a new and unique drug discovery initiative.
Novartis demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Genzyme Receives European Approval of Renvela for Patients with Chronic Kidney Disease
- Details
- Category: Genzyme
![Genzyme Corporation Genzyme Corporation](http://www.worldpharmanews.com/images/stories/logo/genzyme.gif)
Abbott Announces Launch of Next-Generation Embolic Protection System
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Favourable Vote from FDA Advisory Committee on Seroquel Paediatric Applications
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
More Pharma News ...
- Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filing in Europe
- GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China
- Sanofi-aventis to strengthen Insulin Production Capacities
- Novartis announces typhoid vaccine research program in partnership with the Wellcome Trust
- Update on Lu AA21004 clinical development programme in major depressive disorder (MDD)
- World Health Organization grants Global Prequalification to GSK's Rotarix⢠vaccine
- New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure